| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1906.2B | ¥1897.5B | +0.5% |
| Operating Income | ¥139.2B | ¥157.0B | -11.4% |
| Profit Before Tax | ¥157.7B | ¥181.9B | -13.3% |
| Net Income | ¥122.8B | ¥132.6B | -7.4% |
| ROE | 6.2% | 7.2% | - |
FY2026 Q3 results showed revenue of 190.6B yen (YoY +0.5%), maintaining flat growth, while operating income declined to 13.9B yen (YoY -11.4%), reflecting margin compression. Ordinary income was not separately disclosed, and net income attributable to owners reached 12.2B yen (YoY -7.4%). The profit decline was driven by gross margin deterioration to 18.3% and increased selling, general and administrative expenses of 20.8B yen, which grew faster than revenue. Operating cash flow of 17.5B yen demonstrated cash-backed earnings with a 1.43x conversion ratio, though free cash flow of 6.4B yen was constrained by capital expenditures of 10.6B yen and dividend payments of 8.1B yen. The balance sheet remained conservatively capitalized with an equity ratio of 76.8% and cash holdings of 69.8B yen, though working capital efficiency deteriorated with receivables turnover at 77 days and inventory turnover at 84 days.
[Profitability] ROE of 6.2% reflects moderate capital efficiency, calculated from net profit margin of 6.4%, asset turnover of 0.742, and financial leverage of 1.29x. Operating margin decreased to 7.3% from prior year levels, with gross profit margin of 18.3% indicating pricing pressure or product mix deterioration. The decline in profitability was primarily attributed to operating leverage working in reverse, as SG&A expenses grew faster than revenue. [Cash Quality] Cash and equivalents stood at 69.8B yen, providing substantial liquidity buffer. Operating cash flow of 17.5B yen covered net income by 1.43x, confirming solid earnings quality. However, working capital management showed signs of deterioration with days sales outstanding at 77 days and days inventory outstanding at 84 days, both indicating slower asset conversion. [Investment Efficiency] Total asset turnover of 0.742 reflects moderate asset utilization. Capital expenditures of 10.6B yen represented strategic investment, though free cash flow coverage of 0.61x for dividends indicates limited self-funding capacity for shareholder returns. [Financial Health] Equity ratio of 76.8% significantly exceeds industry norms, indicating conservative capitalization. Current ratio of 2.84x provides adequate short-term liquidity coverage. Interest-bearing debt remained minimal at 3.0B yen in short-term borrowings, with interest coverage well maintained. However, quality alerts highlighted short-term debt concentration at 100% of total debt and elevated working capital days, warranting attention to refinancing flexibility and operational efficiency.
Operating cash flow of 17.5B yen represented 1.43x net income, confirming cash-backed earnings quality. The operating cash flow comprised net income of 12.2B yen adjusted for non-cash items including depreciation and other adjustments. Working capital movements showed deterioration with accounts receivable increasing by 0.5B yen and other working capital changes consuming 3.9B yen, reflecting slower collection and inventory turnover. Investing cash flow of 11.1B yen was primarily driven by capital expenditures of 10.6B yen, indicating ongoing facility and equipment investment. Financing cash flow of 8.1B yen reflected dividend payments with no disclosed share buybacks or significant debt changes. Free cash flow of 6.4B yen covered only 79% of dividend payments, leaving a coverage gap of 1.7B yen that was funded from existing cash reserves. The company maintained substantial cash holdings of 69.8B yen, providing buffer for the elevated payout ratio of 85.9%, though the sustainability of current dividend levels warrants monitoring given limited free cash flow generation. Cash and deposits increased 23.5B yen year-over-year, supported by operating profit generation and conservative financial management, though working capital efficiency improvements remain necessary to enhance cash conversion.
Operating income of 13.9B yen represented the core business profitability, while net income of 12.2B yen reflected additional non-operating and tax adjustments. The difference between operating and net income levels indicates non-operating net contributions, including financial income of 0.9B yen and equity method investment gains, partially offset by financial expenses of 0.5B yen. Non-operating income components remained relatively minor relative to total revenue at less than 1%, comprising primarily interest and dividend income. The composition suggests earnings are predominantly driven by core operations rather than financial engineering or one-time gains. Operating cash flow of 17.5B yen exceeded net income by 43%, indicating healthy accrual quality with profits converting to cash effectively. However, working capital metrics showing receivables at 77 days and inventory at 84 days suggest some deterioration in operational efficiency that could affect future cash conversion if unaddressed. The alignment between operating cash flow and reported earnings confirms that profit quality remains fundamentally sound, though attention to working capital management is necessary to sustain this performance.
Margin compression risk from gross profit margin of 18.3% combined with rising SG&A expenses of 20.8B yen, reflecting competitive pricing pressure or unfavorable product mix that reduced operating margin to 7.3%, below the prior year level and requiring cost management or pricing power recovery.
Working capital efficiency deterioration with days sales outstanding at 77 days and days inventory outstanding at 84 days, both indicating slower asset turnover that constrains operating cash flow generation and could signal demand softness or collection challenges requiring operational improvement.
Dividend sustainability pressure from payout ratio of 85.9% and free cash flow coverage of only 0.61x, creating ongoing drain on cash reserves despite current holdings of 69.8B yen, particularly if profitability does not recover to support the 202 yen annual dividend policy under current earnings trajectory.
[Industry Position] (Reference - Proprietary Analysis) Within the manufacturing sector comprising 98 companies for Q3 2025 comparisons, the company demonstrates above-median profitability and significantly superior financial health, while operational efficiency metrics present a mixed profile. Profitability: ROE of 6.2% exceeds the industry median of 5.0% (IQR: 2.9%-8.1%), placing the company in the upper half of peer performance. Operating margin of 7.3% trails the industry median of 8.3% (IQR: 4.8%-12.6%), indicating room for improvement in cost management relative to peers. Net profit margin of 6.4% aligns closely with the industry median of 6.3% (IQR: 3.2%-9.0%), confirming competitive bottom-line efficiency. Financial Health: Equity ratio of 76.8% substantially exceeds the industry median of 63.8% (IQR: 49.5%-74.7%), reflecting exceptionally conservative capitalization that provides strong financial stability but may indicate suboptimal capital structure efficiency. Current ratio of 2.84x matches the industry median exactly (IQR: 2.10x-3.81x), confirming adequate liquidity positioning. Efficiency: Asset turnover of 0.742 exceeds the industry median of 0.58 (IQR: 0.42-0.66), demonstrating superior asset utilization. However, receivables turnover of 77 days compares favorably to the industry median of 82.87 days (IQR: 68.43-115.00), while inventory turnover of 84 days performs better than the industry median of 108.81 days (IQR: 49.60-154.77), suggesting working capital management remains competitive despite recent deterioration. Revenue growth of 0.5% underperforms the industry median of 2.7% (IQR: -1.9%-7.9%), indicating below-average top-line momentum. The company's financial leverage of 1.29x is notably lower than the industry median of 1.53x (IQR: 1.31-1.85), consistent with the elevated equity ratio and conservative debt posture. Overall, the company exhibits strong balance sheet positioning and solid operational efficiency, though profitability margins and growth rates warrant attention relative to industry benchmarks.
Profitability inflection point requires monitoring as the 11.4% operating income decline reflects both gross margin compression to 18.3% and SG&A expense growth outpacing revenue growth of 0.5%, creating urgency for either pricing power recovery or cost rationalization to restore the prior year's higher operating leverage.
Working capital management has emerged as a critical operational focus, with receivables at 77 days and inventory at 84 days consuming cash and constraining free cash flow generation despite healthy operating cash conversion of 1.43x, indicating that improvements in collection efficiency and inventory turnover could meaningfully enhance cash availability.
Capital allocation sustainability faces near-term pressure from the 85.9% payout ratio and 0.61x free cash flow dividend coverage, which relies on the substantial 69.8B yen cash reserve to maintain the 202 yen annual dividend policy, suggesting that either earnings recovery or dividend policy adjustment may become necessary if current profit trajectory persists through the full year forecast of 12.9B yen net income.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.